Results
183
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
183 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CRDO | US$31.35 | 6.0% | 85.4% | US$5.2b | US$29.42 | PS26.8x | E60.9% | n/a | Semiconductors | ||
EH | US$13.77 | 1.0% | -15.9% | US$893.6m | US$24.98 | PS40.4x | E74.3% | n/a | Capital Goods | ||
ATAT | US$18.82 | 4.5% | 3.9% | US$2.6b | US$27.17 | PE19.3x | E22.1% | 0.8% | Consumer Services | ||
GCT | US$31.44 | 7.0% | 339.7% | US$1.3b | US$52.33 | PE12.2x | E21.3% | n/a | Retail | ||
PDD | US$133.88 | -4.4% | 87.8% | US$184.7b | US$205.59 | PE16.9x | E23.2% | n/a | Retail | ||
TBBB | US$23.54 | 1.6% | n/a | US$2.6b | US$27.05 | PS1x | E100.1% | n/a | Consumer Retailing | ||
CG | US$40.01 | 0.5% | 23.6% | US$14.2b | US$48.45 | PS6.5x | E23.6% | 3.5% | Diversified Financials | ||
SMCI | US$837.17 | -0.7% | 235.9% | US$47.6b | US$1,032.47 | PE46.7x | E40.2% | n/a | Tech | ||
DUOL | US$193.89 | -5.4% | 36.2% | US$8.4b | US$252.23 | PE183.3x | E48.1% | n/a | Consumer Services | ||
BRDG | US$7.43 | 2.3% | -35.6% | US$875.9m | US$9.88 | PB3.5x | E98.2% | 8.9% | Diversified Financials | ||
MAX | US$12.69 | -11.2% | 34.0% | US$825.7m | US$25.33 | PS1.6x | E88.1% | n/a | Media | ||
ZKH | US$3.76 | -3.6% | n/a | US$608.8m | US$15.74 | PB1.4x | E104.4% | n/a | Capital Goods | ||
MDGL | US$271.67 | -3.0% | 20.3% | US$6.0b | US$365.07 | PB6.8x | E63.8% | n/a | Pharmaceuticals & Biotech | ||
HSCS | US$5.21 | -2.6% | -94.1% | US$3.3m | US$67.50 | PS183.6x | E66.8% | n/a | Healthcare | ||
CBNK | US$20.37 | 1.9% | 10.8% | US$284.4m | US$26.10 | PB1.1x | E27.2% | 1.6% | Banks | ||
SPRY | US$8.66 | 13.2% | 28.7% | US$845.9m | US$19.00 | PS83911.3x | E58.7% | n/a | Pharmaceuticals & Biotech | ||
RYAN | US$57.35 | -2.8% | 28.6% | US$14.8b | US$58.08 | PE107.3x | E56.6% | 0.8% | Insurance | ||
EVOK | US$0.51 | 1.5% | -68.2% | US$4.1m | US$7.00 | PB1.2x | E110.6% | n/a | Pharmaceuticals & Biotech | ||
HSAI | US$4.35 | 3.8% | -61.6% | US$553.3m | US$10.07 | PS2.2x | E71.0% | n/a | Automobiles | ||
ESTA | US$42.75 | -4.0% | -36.3% | US$1.2b | US$65.14 | PS7.6x | E68.2% | n/a | Healthcare | ||
LOOP | US$2.11 | -1.4% | -39.5% | US$101.7m | US$7.25 | PS655.6x | E71.5% | n/a | Materials | ||
ALKT | US$30.30 | 14.4% | 86.2% | US$2.8b | US$29.80 | PS10.5x | E92.1% | n/a | Software | ||
CARG | US$25.49 | 1.3% | 12.4% | US$2.6b | US$26.62 | PE73.2x | E30.0% | n/a | Media | ||
WULF | US$5.05 | 5.2% | 150.0% | US$1.7b | US$6.10 | PS16.8x | E91.8% | n/a | Software |